Home -> Law Blog Directory -> Personal Injury Law Blogs -> Georgia Injury Lawyer Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Georgia Injury Lawyer BlogDigoxin and Byetta: Dangerous Drug Products
Digoxin was developed by the company Actavis Totowa to treat arrhythmias (abnormal heat rhythm) and allegedly to prevent heart failure. In April of this year, the U.S. Food and Drug Administration issued a recall of this drug. As it turned out, the use of this product leads to a dangerous side effect known as digitalis toxicity, a process that occurs when digitalis is not excreted normally through urine and the body is overexposed to the drug. This process may be fatal to the victim, which is why this drug was recalled from the market.
We had previously written a blog about Byetta developed by Eli Lilly and Company and Amylin Pharmaceuticals, Inc. This drug is used in the treatment of Type 2 diabetes, however, reports of patients developing pancreatitis, a potentially deadly side effect, occurred late in the 2007 period and have been increasing since that time. Indeed, in the fall of this year, a lawsuit was filed in California by a plaintiff who had been hospitalized for pancreatitis.
It seem as though there are new drugs coming to market almost everyday. Television ads about drugs are omnipresent. These two drugs, two among hundreds of other drug products, help to demonstrate the dangers associated with drugs that are not carefully screened by a manufacturer before being placed into the marketplace. Consumers now, more than ever, must be made aware of the dangers associated with drug treatment. The American public clearly is using more and more drug treatment. For this reason alone, it is increasingly imperative that manufacturers provide adequate warnings to patients and their physicians of dangers known to be associated with these products. Side effects can be deadly when powerful medications are involved and the public has a right to know of these dangers.
Our firm will continue to blog about these and other dangerous drugs in the future in an effort to warn the public of the dangers associated with their use. Regrettably, litigation may be the best available tool to insure that manufacturers will provide better and more informative warnings on their products so that consumers can make educated decisions about the risks and benefits of using these products.
Full post as published by Georgia Injury Lawyer Blog on October 16, 2008 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
UPDATE 1: Caraco Digoxin Recall
Digoxin Recalled
Due to Irregular Sized Tablets
Caraco Brand 0.25 mg Digoxin Tablets Recalled
due to Size Variability
Plavix and Nexium
A Potentially Dangerous Combination

Diabetes Drug, Byetta, Shows a Life-Extending Promise
FDA Reports 2 Deaths Linked to Byetta Diabetes Drug
Byetta Side Effects a Fact of Life
Diabetes Drug Byetta Linked to Two Deaths
FDA updates pancreatitis warning on Byetta label
Diabetes Drug Tied to New Deaths








